Logo image of MYRG

MYR GROUP INC/DELAWARE (MYRG) Stock Fundamental Analysis

NASDAQ:MYRG - Nasdaq - US55405W1045 - Common Stock - Currency: USD

169.34  +1.39 (+0.83%)

After market: 169.34 0 (0%)

Fundamental Rating

5

Overall MYRG gets a fundamental rating of 5 out of 10. We evaluated MYRG against 51 industry peers in the Construction & Engineering industry. While MYRG has a great health rating, there are worries on its profitability. MYRG has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year MYRG was profitable.
MYRG had a positive operating cash flow in the past year.
MYRG had positive earnings in each of the past 5 years.
In the past 5 years MYRG always reported a positive cash flow from operatings.
MYRG Yearly Net Income VS EBIT VS OCF VS FCFMYRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

1.2 Ratios

MYRG has a Return On Assets (2.28%) which is in line with its industry peers.
With a Return On Equity value of 6.31%, MYRG perfoms like the industry average, outperforming 52.94% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 5.07%, MYRG is in line with its industry, outperforming 52.94% of the companies in the same industry.
MYRG had an Average Return On Invested Capital over the past 3 years of 8.30%. This is significantly below the industry average of 16.60%.
Industry RankSector Rank
ROA 2.28%
ROE 6.31%
ROIC 5.07%
ROA(3y)4.55%
ROA(5y)5.43%
ROE(3y)11.3%
ROE(5y)12.79%
ROIC(3y)8.3%
ROIC(5y)9.63%
MYRG Yearly ROA, ROE, ROICMYRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a Profit Margin value of 1.02%, MYRG perfoms like the industry average, outperforming 45.10% of the companies in the same industry.
MYRG's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 1.71%, MYRG is not doing good in the industry: 60.78% of the companies in the same industry are doing better.
MYRG's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 8.90%, MYRG is not doing good in the industry: 68.63% of the companies in the same industry are doing better.
MYRG's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.71%
PM (TTM) 1.02%
GM 8.9%
OM growth 3Y-32.77%
OM growth 5Y-11.54%
PM growth 3Y-35.81%
PM growth 5Y-13.14%
GM growth 3Y-12.77%
GM growth 5Y-3.54%
MYRG Yearly Profit, Operating, Gross MarginsMYRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

More info and screens

7

2. Health

2.1 Basic Checks

MYRG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for MYRG has been reduced compared to 1 year ago.
The number of shares outstanding for MYRG has been reduced compared to 5 years ago.
The debt/assets ratio for MYRG is higher compared to a year ago.
MYRG Yearly Shares OutstandingMYRG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MYRG Yearly Total Debt VS Total AssetsMYRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

MYRG has an Altman-Z score of 4.51. This indicates that MYRG is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.51, MYRG is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
The Debt to FCF ratio of MYRG is 0.90, which is an excellent value as it means it would take MYRG, only 0.90 years of fcf income to pay off all of its debts.
MYRG's Debt to FCF ratio of 0.90 is amongst the best of the industry. MYRG outperforms 84.31% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that MYRG is not too dependend on debt financing.
MYRG has a Debt to Equity ratio of 0.15. This is in the better half of the industry: MYRG outperforms 78.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 0.9
Altman-Z 4.51
ROIC/WACC0.5
WACC10.08%
MYRG Yearly LT Debt VS Equity VS FCFMYRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

MYRG has a Current Ratio of 1.31. This is a normal value and indicates that MYRG is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.31, MYRG perfoms like the industry average, outperforming 54.90% of the companies in the same industry.
A Quick Ratio of 1.31 indicates that MYRG should not have too much problems paying its short term obligations.
MYRG's Quick ratio of 1.31 is fine compared to the rest of the industry. MYRG outperforms 62.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
MYRG Yearly Current Assets VS Current LiabilitesMYRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for MYRG have decreased strongly by -27.52% in the last year.
The Earnings Per Share has been growing by 8.67% on average over the past years. This is quite good.
The Revenue has decreased by -7.33% in the past year.
The Revenue has been growing by 10.17% on average over the past years. This is quite good.
EPS 1Y (TTM)-27.52%
EPS 3Y-11.74%
EPS 5Y8.67%
EPS Q2Q%29.46%
Revenue 1Y (TTM)-7.33%
Revenue growth 3Y10.41%
Revenue growth 5Y10.17%
Sales Q2Q%2.21%

3.2 Future

MYRG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.88% yearly.
The Revenue is expected to grow by 6.60% on average over the next years.
EPS Next Y91.38%
EPS Next 2Y50.9%
EPS Next 3Y39.88%
EPS Next 5YN/A
Revenue Next Year1.69%
Revenue Next 2Y3.58%
Revenue Next 3Y6.6%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MYRG Yearly Revenue VS EstimatesMYRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
MYRG Yearly EPS VS EstimatesMYRG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 45.28, which means the current valuation is very expensive for MYRG.
Compared to the rest of the industry, the Price/Earnings ratio of MYRG is on the same level as its industry peers.
MYRG's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.35.
The Price/Forward Earnings ratio is 21.81, which indicates a rather expensive current valuation of MYRG.
MYRG's Price/Forward Earnings is on the same level as the industry average.
MYRG is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 45.28
Fwd PE 21.81
MYRG Price Earnings VS Forward Price EarningsMYRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MYRG.
Based on the Price/Free Cash Flow ratio, MYRG is valued a bit cheaper than 62.75% of the companies in the same industry.
Industry RankSector Rank
P/FCF 26.42
EV/EBITDA 21.8
MYRG Per share dataMYRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

MYRG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MYRG's earnings are expected to grow with 39.88% in the coming years.
PEG (NY)0.5
PEG (5Y)5.22
EPS Next 2Y50.9%
EPS Next 3Y39.88%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MYRG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MYR GROUP INC/DELAWARE

NASDAQ:MYRG (6/20/2025, 8:00:02 PM)

After market: 169.34 0 (0%)

169.34

+1.39 (+0.83%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners102.9%
Inst Owner Change-0.98%
Ins Owners1.75%
Ins Owner Change2.83%
Market Cap2.63B
Analysts85
Price Target166.43 (-1.72%)
Short Float %5.08%
Short Ratio3.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.89%
Min EPS beat(2)18.63%
Max EPS beat(2)39.15%
EPS beat(4)4
Avg EPS beat(4)56.53%
Min EPS beat(4)18.63%
Max EPS beat(4)84.18%
EPS beat(8)5
Avg EPS beat(8)26.57%
EPS beat(12)7
Avg EPS beat(12)22.39%
EPS beat(16)11
Avg EPS beat(16)20.01%
Revenue beat(2)1
Avg Revenue beat(2)-2.13%
Min Revenue beat(2)-8.24%
Max Revenue beat(2)3.99%
Revenue beat(4)1
Avg Revenue beat(4)-3.6%
Min Revenue beat(4)-8.24%
Max Revenue beat(4)3.99%
Revenue beat(8)4
Avg Revenue beat(8)0.55%
Revenue beat(12)8
Avg Revenue beat(12)3.22%
Revenue beat(16)11
Avg Revenue beat(16)3%
PT rev (1m)2.51%
PT rev (3m)-3.26%
EPS NQ rev (1m)3.98%
EPS NQ rev (3m)-8.86%
EPS NY rev (1m)0%
EPS NY rev (3m)4.16%
Revenue NQ rev (1m)0.78%
Revenue NQ rev (3m)-9.87%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.37%
Valuation
Industry RankSector Rank
PE 45.28
Fwd PE 21.81
P/S 0.78
P/FCF 26.42
P/OCF 16.15
P/B 4.79
P/tB 7.28
EV/EBITDA 21.8
EPS(TTM)3.74
EY2.21%
EPS(NY)7.76
Fwd EY4.59%
FCF(TTM)6.41
FCFY3.79%
OCF(TTM)10.48
OCFY6.19%
SpS217.81
BVpS35.35
TBVpS23.27
PEG (NY)0.5
PEG (5Y)5.22
Profitability
Industry RankSector Rank
ROA 2.28%
ROE 6.31%
ROCE 7.36%
ROIC 5.07%
ROICexc 5.14%
ROICexgc 6.79%
OM 1.71%
PM (TTM) 1.02%
GM 8.9%
FCFM 2.94%
ROA(3y)4.55%
ROA(5y)5.43%
ROE(3y)11.3%
ROE(5y)12.79%
ROIC(3y)8.3%
ROIC(5y)9.63%
ROICexc(3y)8.68%
ROICexc(5y)10.33%
ROICexgc(3y)11.86%
ROICexgc(5y)13.66%
ROCE(3y)12.04%
ROCE(5y)13.96%
ROICexcg growth 3Y-34.99%
ROICexcg growth 5Y-7.87%
ROICexc growth 3Y-35.45%
ROICexc growth 5Y-8.52%
OM growth 3Y-32.77%
OM growth 5Y-11.54%
PM growth 3Y-35.81%
PM growth 5Y-13.14%
GM growth 3Y-12.77%
GM growth 5Y-3.54%
F-Score4
Asset Turnover2.22
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 0.9
Debt/EBITDA 0.69
Cap/Depr 96.44%
Cap/Sales 1.87%
Interest Coverage 250
Cash Conversion 132.09%
Profit Quality 287.28%
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 4.51
F-Score4
WACC10.08%
ROIC/WACC0.5
Cap/Depr(3y)130.75%
Cap/Depr(5y)120.21%
Cap/Sales(3y)2.38%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.52%
EPS 3Y-11.74%
EPS 5Y8.67%
EPS Q2Q%29.46%
EPS Next Y91.38%
EPS Next 2Y50.9%
EPS Next 3Y39.88%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.33%
Revenue growth 3Y10.41%
Revenue growth 5Y10.17%
Sales Q2Q%2.21%
Revenue Next Year1.69%
Revenue Next 2Y3.58%
Revenue Next 3Y6.6%
Revenue Next 5YN/A
EBIT growth 1Y-52.55%
EBIT growth 3Y-25.77%
EBIT growth 5Y-2.54%
EBIT Next Year383.08%
EBIT Next 3Y83.95%
EBIT Next 5YN/A
FCF growth 1Y-1.05%
FCF growth 3Y-49.12%
FCF growth 5Y9.5%
OCF growth 1Y-11.17%
OCF growth 3Y-14.06%
OCF growth 5Y6.06%